The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarlowe Regulatory News (MRL)

Share Price Information for Marlowe (MRL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 508.00
Bid: 506.00
Ask: 510.00
Change: 0.00 (0.00%)
Spread: 4.00 (0.791%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 508.00
MRL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

2020 SAYE Scheme & Director/PDMR Shareholdings

2 Sep 2020 07:00

RNS Number : 7402X
Marlowe PLC
02 September 2020
 

2 September 2020

 

Marlowe plc

 

Launch of Group 2020 SAYE Scheme

Grant of 2020 SAYE Options

Director/PDMR Shareholdings

 

Marlowe plc ("Marlowe" or the "Group"), the specialist services group focused on developing companies which assure safety and regulatory compliance, announces that as part of the Group's HMRC approved 2020 Save As You Earn scheme (the "2020 SAYE Scheme") a total of 699,000 options to subscribe for ordinary shares of 50 pence each in the capital of the Group ("2020 SAYE Options") have today been granted to employees of the Group.

 

Under the 2020 SAYE scheme, which was made available to all Marlowe employees, a total of 617 employees of the Group, including four directors of the Group, have applied to participate in the 2020 SAYE Scheme. The 2020 SAYE Options have an exercise price, calculated in accordance with the rules of the SAYE Scheme, of 460 pence per 2020 SAYE Option. Subject to the rules of the 2020 SAYE Scheme, participants will be able to exercise their 2020 SAYE Options within six-months commencing from 1 October 2023.

 

The following Directors of the Group applied to participate in the 2020 SAYE Scheme and have been granted 2020 SAYE Options in the amounts shown below:

 

Director

2020 SAYE Options Granted

Exercise Price

Exercise Date

Alex Dacre

3,913

460p

1 October 2023

Mark Adams

3,913

460p

1 October 2023

Kevin Quinn

3,913

460p

1 October 2023

Charles Skinner

3,913

460p

1 October 2023

 

As a result of the above grant of 2020 SAYE Options, the Group has a total of 699,000 options over ordinary shares outstanding, representing approximately 1.28 per cent. of the Group issued ordinary share capital.

 

The notifications below, made in accordance with the EU Market Abuse Regulation, provide further details in relation to the grant of 2020 SAYE Options to the Directors.

 

 

For further information:

 

Marlowe plc

www.marloweplc.com

Alex Dacre, Chief Executive

Tel: +44 (0) 203 841 6194

Mark Adams, Group Finance Director

IR@marloweplc.com

Cenkos Securities plc - Nominated Adviser & Joint Broker

Nicholas Wells

Tel: +44 (0)20 7397 8900

Ben Jeynes

Harry Hargreaves

Joh. Berenberg, Gossler & Co. KG, London Branch - Joint Broker

Mark Whitmore

Ben Wright

Tel: +44 (0)20 3207 7800

Yudith Karunaratna

FTI Consulting

Nick Hasell

Tel: +44 (0)20 3727 1340

Alex Le May

 

 

 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Alex Dacre

2

Reason for the notification

a)

Position/status

Chief Executive

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Marlowe plc

b)

LEI

213800ZWSR4SBOM6B608

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 50 pence each

Identification code

ISIN: GB00BD8SLV43

b)

Nature of the transaction

Grant of options over ordinary shares

c)

 

Price(s) and volume(s)

 

 

 

 

 

Price(s)

Volume(s)

 

 

-

3,913

 

 

 

 

 

d)

 

Aggregated information

- Aggregated volume

3,913

- Price

-

e)

Date of the transaction

1 September 2020

f)

Place of the transaction

Outside of a trading venue

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Mark Adams

2

Reason for the notification

a)

Position/status

Group Finance Director

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Marlowe plc

b)

LEI

213800ZWSR4SBOM6B608

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 50 pence each

Identification code

ISIN: GB00BD8SLV43

b)

Nature of the transaction

Grant of options over ordinary shares

c)

 

Price(s) and volume(s)

 

 

 

 

 

Price(s)

Volume(s)

 

 

-

3,913

 

 

 

 

 

d)

 

Aggregated information

- Aggregated volume

3,913

- Price

-

e)

Date of the transaction

1 September 2020

f)

Place of the transaction

Outside of a trading venue

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Kevin Quinn

2

Reason for the notification

a)

Position/status

Chairman

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Marlowe plc

b)

LEI

213800ZWSR4SBOM6B608

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 50 pence each

Identification code

ISIN: GB00BD8SLV43

b)

Nature of the transaction

Grant of options over ordinary shares

c)

 

Price(s) and volume(s)

 

 

 

 

 

Price(s)

Volume(s)

 

 

-

3,913

 

 

 

 

 

d)

 

Aggregated information

- Aggregated volume

3,913

- Price

-

e)

Date of the transaction

1 September 2020

f)

Place of the transaction

Outside of a trading venue

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Charles Skinner

2

Reason for the notification

a)

Position/status

Non-Executive Director

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Marlowe plc

b)

LEI

213800ZWSR4SBOM6B608

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 50 pence each

Identification code

ISIN: GB00BD8SLV43

b)

Nature of the transaction

Grant of options over ordinary shares

c)

 

Price(s) and volume(s)

 

 

 

 

 

Price(s)

Volume(s)

 

 

-

3,913

 

 

 

 

 

d)

 

Aggregated information

- Aggregated volume

3,913

- Price

-

e)

Date of the transaction

1 September 2020

f)

Place of the transaction

Outside of a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHDZGGLLMFGGZM
Date   Source Headline
11th Oct 20221:40 pmRNSHolding(s) in Company
10th Oct 20222:06 pmRNSHolding(s) in Company
21st Sep 20224:18 pmRNSHolding(s) in Company
20th Sep 20222:02 pmRNSHolding(s) in Company
14th Sep 202211:56 amRNSResult of Annual General Meeting
14th Sep 20227:00 amRNSAGM Statement
2nd Sep 20229:41 amRNSHolding(s) in Company
30th Aug 20227:00 amRNSLaunch of Group 2022 SAYE Scheme
16th Aug 20223:38 pmRNSExercise of Share Options and Total Voting Rights
9th Aug 20227:00 amRNSPublication of Notice of AGM and Annual Report
8th Aug 20227:00 amRNSChange of Auditor
7th Jul 20225:14 pmRNSDirector/PDMR Shareholding
5th Jul 20222:24 pmRNSExercise of Share Options and Total Voting Rights
4th Jul 20223:54 pmRNSExercise of Share Options and Total Voting Rights
4th Jul 20222:10 pmRNSDirector/PDMR Shareholding
1st Jul 20227:00 amRNSPublication of Annual Report
28th Jun 20227:00 amRNSFinal Results
23rd Jun 20227:00 amRNSNotice of Full Year Results Analyst Presentation
8th Jun 20227:00 amRNSAcquisition of HR Solutions
25th May 20227:00 amRNSAcquisition of Cedrec Information Systems Limited
23rd May 202212:55 pmRNSExercise of Share Options and Total Voting Rights
28th Apr 20224:22 pmRNSHolding(s) in Company
28th Apr 20224:18 pmRNSHolding(s) in Company
26th Apr 20224:36 pmRNSExercise of Share Options and Total Voting Rights
19th Apr 20227:00 amRNSAcquisition of TP Health
11th Apr 202210:47 amRNSExercise of Share Options
5th Apr 20223:05 pmRNSCapital Markets Day Replay
5th Apr 20227:00 amRNSCapital Markets Day
22nd Mar 20227:00 amRNSAcquisition of Griffin Fire
21st Mar 20227:00 amRNSNotice of Capital Markets Day and Trading Update
15th Mar 20227:00 amRNSAppointment of Joint Corporate Broker
17th Feb 20227:00 amRNSDirectorate Change
11th Feb 20227:00 amRNSAcquisition of S F Fire Limited
10th Feb 20227:00 amRNSNew Enlarged Debt Facility
31st Jan 202212:20 pmRNSHolding(s) in Company
28th Jan 20222:19 pmRNSDirector/PDMR Shareholding
27th Jan 20229:07 amRNSHolding(s) in Company
26th Jan 202211:39 amRNSDirector/PDMR Shareholding
26th Jan 20227:00 amRNSIssue of Equity and Total Voting Rights
21st Jan 20221:08 pmRNSHolding(s) in Company
20th Jan 20224:08 pmRNSResults of Placing
20th Jan 20227:48 amRNSProposed Placing and Acquisition of Optima Health
20th Jan 20227:00 amRNSAcquisition of Optima Health
19th Jan 202212:13 pmRNSAppointment of Independent Non-Executive Director
14th Jan 20225:01 pmRNSExercise of Share Options
20th Dec 20217:00 amRNSAcquisition of Skill Boosters
14th Dec 202111:12 amRNSHolding(s) in Company
1st Dec 20212:00 pmRNSHalf Year Results Presentation Replay
1st Dec 20217:00 amRNSHalf Year Results
24th Nov 20217:00 amRNSTrading Update and Notice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.